Association of antimalarial drugs with decreased overall and cause specific mortality in systemic lupus erythematosus

Abstract

Antimalarial drugs were associated with lower risk of SLE mortality, especially renal insufficiency- and other organ involvement-related death. The protective effects for survival might be augmented by adherence and full dosage of these drugs.